Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes

Journal of Clinical Investigation

Volumn 100, Issue 2, 1997, Pages 449-458

  Ahmad, Faiyaz ^a   Azevedo Jr , John L ^b   Cortright, Ronald ^b   Dohm, G Lynis ^b   Goldstein, Barry J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Insulin receptor; Insulin resistance; Protein phosphatase; Signal transduction; Tyrosine kinase

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; FAST PROTEIN LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INSULIN RESISTANCE; MUSCLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SKELETAL MUSCLE; TISSUE HOMOGENATE;

EID: 0030840724     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119552     Document Type: Article

References (54)

1. Rabinowitz, D. 1970. Some endocrine and metabolic aspects of obesity. Annu. Rev. Med. 21:241-258.
2. Kolterman, O.G., J. Insel, M. Saekow, and J.M. Olefsky. 1980. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J. Clin. Invest. 65:1272-1284.
3. Caro, J.F. 1991. Clinical Review 26: insulin resistance in obese and non-obese man. J. Clin. Endocrinol. Metab. 73:691-695.
4. White, M.F., and C.R. Kahn. 1994. The insulin signaling system. J. Biol. Chem. 269:1-4.
5. Goldstein, B.J. 1993. Regulation of insulin receptor signaling by protein-tyrosine dephosphorylation. Receptor. 3:1-15.
6. Fischer, E.H., H. Charbonneau, and N.K. Tonks. 1991. Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science (Wash. DC). 253:401-406.
7. Streuli, M., N.X. Krueger, L.R. Hall, S.F. Schlossman, and H. Saito. 1988. A new member of the immunoglobulin superfamily that has a cytoplasmic region homologous to the leukocyte common antigen. J. Exp. Med. 168:1523-1530.
8. Sap, J., P. D'Eustachio, D. Givol, and J. Schlessinger. 1990. Cloning and expression of a widely expressed receptor tyrosine phosphatase. Proc. Natl. Acad. Sci. USA. 87:6112-6116.
9. Chernoff, J., A.R. Schievella, C.A. Jost, R.L. Erikson, and B.G. Neel. 1990. Cloning of a cDNA for a major human protein-tyrosine-phosphatase. Proc. Natl. Acad. Sci. USA. 87:2735-2739.
10. Guan, K.L., R.S. Haun, S.J. Watson, R.L. Geahlen, and J.E. Dixon. 1990. Cloning and expression of a protein-tyrosine-phosphatase. Proc. Natl. Acad. Sci. USA. 87:1501-1505.
11. Freeman, R.M., J. Plutzky, and B.G. Neel. 1992. Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of drosophila corkscrew. Proc. Natl. Acad. Sci. USA. 89:11239-11243.
12. Ding, W., W.R. Zhang, K. Sullivan, N. Hashimoto, and B.J. Goldstein. 1994. Identification of protein-tyrosine phosphatases prevalent in adipocytes by molecular cloning. Biochem. Biophys. Res. Commun. 202:902-907.
13. Li, P.M., W.R. Zhang, and B.J. Goldstein. 1996. Suppression of insulin receptor activation by overexpression of the protein-tyrosine phosphatase LAR in hepatoma cells. Cell. Signaling. 8:467-473.
14. Zhang, W.R., P.M. Li, M.A. Oswald, and B.J. Goldstein. 1996. Modulation of insulin signal transduction by eutopic overexpression of the receptor-type protein-tyrosine phosphatase LAR. Mol. Endocrinol. 10:575-584.
15. Moller, N.P.H., K.B. Moller, R. Lammers, A. Kharitonenkov, E. Hoppe, F.C. Wiberg, I. Sures, and A. Ullrich. 1995. Selective down-regulation of the insulin receptor signal by protein-tyrosine phosphatases alpha and epsilon. J. Biol. Chem. 270:23126-23131.
16. Kulas, D.T., W.R. Zhang, B.J. Goldstein, R.W. Furlanetto, and R.A. Mooney. 1995. Insulin receptor signaling is augmented by antisense inhibition of the protein-tyrosine phosphatase LAR. J. Biol. Chem. 270:2435-2438.
17. Kenner, K.A., E. Anyanwu, J.M. Olefsky, and J. Kusari. 1996. Protein-tyrosine phosphatase 1B is a negative regulator of insulin-and insulin-like growth factor-1 stimulated signaling. J. Biol. Chem. 271:19810-19816.
18. Ahmad, F., P.M. Li, J. Meyerovitch, and B.J. Goldstein. 1995. Osmotic loading of neutralizing antibodies defines a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway. J. Biol. Chem. 270:20503-20508.
19. Lammers, R., B. Bossenmaier, D.E. Cool, N.K. Tonks, J. Schlessinger, E.H. Fischer, and A. Ullrich. 1993. Differential activities of protein tyrosine phosphatases in intact cells. J. Biol. Chem. 268:22456-22462.
20. Kuhné, M.R., T. Pawson, G.E. Lienhard, and G.S. Feng. 1993. The insulin receptor substrate-1 associates with the SH2-containing phosphotyrosine phosphatase Syp. J. Biol. Chem. 268:11479-11481.
21. Xiao, S., D.W. Rose, T. Sasaoka, H. Maegawa, T.R. Burke, P.P. Roller, S.E. Shoelson, and J.M. Olefsky. 1994. Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. J. Biol. Chem. 269: 21244-21248.
22. Milarski, K.L., and A.R. Saltiel. 1994. Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J. Biol. Chem. 269:21239-21243.
23. Ahmad, F., R.V. Considine, and B.J. Goldstein. 1995. Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. J. Clin. Invest. 95:2806-2812.
24. Ahmad, F., R.V. Considine, T.L. Bauer, J.P. Ohannesian, C.C. Marco, and B.J. Goldstein. 1997. Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue. Metab. Clin. Exp. In press.
25. DeFronzo, R.A., R.C. Bonadonna, and E. Ferrannini. 1992. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 15:318-368.
26. National Diabetes Data Group. 1979. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 28:1039-1057.
27. Dohm, G.L., E.B. Tapscott, W.J. Pories, D.J. Dabbs, E.G. Flickinger, D. Meelheim, T. Fushiki, S.M. Alkinson, C.W. Elton, and J.F. Caro. 1988. An in vitro human muscle preparation suitable for metabolic studies. J. Clin. Invest. 82:486-494.
28. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
29. Kasuga, M., M.F. White, and C.R. Kahn. 1985. Phosphorylation of the insulin receptor in cultured hepatoma cells and a solubilized system. Methods Enzymol. 109:609-621.
30. Hashimoto, N., E.P. Feener, W.R. Zhang, and B.J. Goldstein. 1992. Insulin receptor protein-tyrosine phosphatases-leukocyte common antigen-related phosphatase rapidly deactivates the insulin receptor kinase by preferential dephosphorylation of the receptor regulatory domain. J. Biol. Chem. 267: 13811-13814.
31. 4. Nature (Lond.). 227:680-685.
32. Tonks, N.K., C.D. Diltz, and E.H. Fischer. 1991. Purification and assay of CD45: an integral membrane protein-tyrosine phosphatase. Methods Enzymol. 201:442-451.
33. Ahmad, F., and B.J. Goldstein. 1995. Purification, identification and subcellular distribution of three predominant protein-tyrosine phosphatase enzymes in skeletal muscle tissue. Biochim. Biophys. Acta. 1248:57-69.
34. Haring, H.U., and H. Mehnert. 1993. Pathogenesis of type-2 (non-insulin-dependent) diabetes-mellitus-candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle. Diabetologia. 36:176-182.
35. Caro, J.F., L.G. Dohm, W.J. Pories, and M.K. Sinha. 1989. Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes. Diabetes Metab. Rev. 5:665-689.
36. Goodyear, L.J., F. Giorgino, L.A. Sherman, J. Carey, R.J. Smith, and G.L.Dohm. 1995. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J. Clin. Invest. 95:2195-2204.
37. Goldstein, B.J. 1996. Protein-tyrosine phosphatases and the regulation of insulin action. In Diabetes Mellitus: A Fundamental and Clinical Text. D. LeRoith, J.M. Olefsky, and S.I. Taylor, editors. Lippincott Raven Publishers, Philadelphia. 174-186.
38. McGuire, M.C., R.M. Fields, B.L. Nyomba, I. Raz, C. Bogardus, N.K. Tonks, and J. Sommercorn. 1991. Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans. Diabetes. 40:939-942.
39. Ahmad, F., and B.J. Goldstein. 1997. Functional association between the insulin receptor and the transmembrane protein-tyrosine phosphatase LAR in intact cells. J. Biol. Chem. 272:448-457.
40. Cicirelli, M.F., N.K. Tonks, C.D. Diltz, J.E. Weiel, E.H. Fischer, and E.G. Krebs. 1990. Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes. Proc. Natl. Acad. Sci. USA. 87:5514-5518.
41. Tonks, N.K., M.F. Cicirelli, C.D. Diltz, E.G. Krebs, and E.H. Fischer. 1990. Effect of microinjection of a low-Mr human placenta protein tyrosine phosphatase on induction of meiotic cell division in Xenopus oocytes. Mol. Cell. biol. 10:458-463.
42. Yamauchi, K., K.L. Milarski, A.R. Saltiel, and J.E. Pessin. 1995. Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling. Proc. Natl. Acad. Sci. USA. 92:664-668.
43. Noguchi, T., T. Matozaki, K. Horita, Y. Fujioka, and M. Kasuga. 1994. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains in insulin-stimulated ras activation. Mol. Cell. Biol. 14:6674-6682.
44. Worm, D., J. Vinten, P. Staehr, J.E. Henriksen, A. Handberg, and H. Beck-Nielsen. 1996. Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle fractions from NIDDM patients compared with control subjects. Diabetologia. 39:1208-1214.
45. Kusari, J., K.A. Kenner, K.I. Suh, D.E. Hill, and R.R. Henry. 1994. Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance. J. Clin. Invest. 93:1156-1162.
46. Sredy, J., D.R. Sawicki, B.R. Flam, and D. Sullivan. 1995. Insulin resistance is associated with abnormal dephosphorylation of a synthetic phosphopeptide corresponding to the major autophosphorylation sites of the insulin receptor. Metab. Clin. Exp. 44:1074-1081.
47. Meyerovitch, J., J.M. Backer, and C.R. Kahn. 1989. Hepatic phosphotyrosine phosphatase activity and its alteration in diabetic rats. J. Clin. Invest. 84: 976-983.
48. Hauguel deMouzon, S., P. Peraldi, F. Alengrin, and E. Van Obberghen. 1993. Alteration of phosphotyrosine phosphatase activity in tissues from diabetic and pregnant rats. Endocrinology. 132:67-74.
49. Gruppuso, P.A., J.M. Boylan, B.I. Posner, R. Faure, and D.L. Brautigan. 1990. Hepatic protein phosphotyrosine phosphatase. Dephosphorylation of insulin and epidermal growth factor receptors in normal and alloxan diabetic rats. J. Clin. Invest. 85:1754-1760.
50. Ahmad, F., and B.J. Goldstein. 1995. Alterations in specific protein-tyrosine phosphatases accompany the insulin resistance of streptozotocin-diabetes. Am. J. Physiol. 268:E932-E940.
51. Meyerovitch, J., J.M. Backer, P. Csermely, S.E. Shoelson, and C.R. Kahn. 1992. Insulin differentially regulates protein phosphotyrosine phosphatase activity in rat hepatoma cells. Biochemistry. 31:10338-10344.
52. Hashimoto, N., and B.J. Goldstein. 1992. Differential regulation of mRNAs encoding three protein-tyrosine phosphatases by insulin and activation of protein kinase C. Biochem. Biophys. Res. Commun. 188:1305-1311.
53. Kenner, K.A., D.E. Hill, J.M. Olefsky, and J. Kusari. 1993. Regulation of protein tyrosine phosphatases by insulin and insulin-like growth factor-I. J. Biol. Chem. 268:25455-25462.
54. Friedman, J.E., J.F. Caro, W.J. Pories, J.L. Azevedo, and G.L. Dohm. 1994. Glucose metabolism in incubated human muscle: effect of obesity and non-insulin-dependent diabetes mellitus. Metab. Clin. Exp. 43:1047-1054.